×
Entrez Id:
1591
Gene Symbol:
CYP24A1
CYP24A1
0.400
Biomarker
phenotype
CTD_human
Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.
22337913
2012
×
Entrez Id:
6569
Gene Symbol:
SLC34A1
SLC34A1
0.400
Biomarker
phenotype
CTD_human
Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.
9560283
1998
×
Entrez Id:
6569
Gene Symbol:
SLC34A1
SLC34A1
0.400
Biomarker
phenotype
HPO
×
Entrez Id:
1591
Gene Symbol:
CYP24A1
CYP24A1
0.400
Biomarker
phenotype
HPO
×
Entrez Id:
846
Gene Symbol:
CASR
CASR
0.310
Biomarker
phenotype
RGD
Effect of silencing VDR gene in kidney on renal epithelial calcium transporter proteins and urinary calcium excretion in genetic hypercalciuric stone-forming rats.
22137721
2011
×
Entrez Id:
846
Gene Symbol:
CASR
CASR
0.310
GeneticVariation
phenotype
LHGDN
R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria.
17332735
2007
×
Entrez Id:
846
Gene Symbol:
CASR
CASR
0.310
Biomarker
phenotype
HPO
×
Entrez Id:
5741
Gene Symbol:
PTH
PTH
0.300
Biomarker
phenotype
CTD_human
Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis.
17164314
2007
×
Entrez Id:
5443
Gene Symbol:
POMC
POMC
0.300
Biomarker
phenotype
CTD_human
Thiazide therapy for ACTH-induced hypercalciuria and nephrolithiasis.
1324751
1992
×
Entrez Id:
5443
Gene Symbol:
POMC
POMC
0.300
Biomarker
phenotype
CTD_human
Disturbed calcium and phosphate homeostasis during treatment with ACTH of infantile spasms.
3017235
1986
×
Entrez Id:
7421
Gene Symbol:
VDR
VDR
0.200
Biomarker
phenotype
RGD
Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail.
19929616
2010
×
Entrez Id:
142680
Gene Symbol:
SLC34A3
SLC34A3
0.110
GeneticVariation
phenotype
LHGDN
A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc.
18480181
2008
×
Entrez Id:
10686
Gene Symbol:
CLDN16
CLDN16
0.110
GeneticVariation
phenotype
LHGDN
CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
18003771
2008
×
Entrez Id:
10686
Gene Symbol:
CLDN16
CLDN16
0.110
CausalMutation
phenotype
CLINVAR
×
Entrez Id:
10686
Gene Symbol:
CLDN16
CLDN16
0.110
Biomarker
phenotype
HPO
×
Entrez Id:
142680
Gene Symbol:
SLC34A3
SLC34A3
0.110
Biomarker
phenotype
HPO
×
Entrez Id:
84617
Gene Symbol:
TUBB6
TUBB6
0.100
CausalMutation
phenotype
CLINVAR
Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias.
20725928
2010
×
Entrez Id:
10939
Gene Symbol:
AFG3L2
AFG3L2
0.100
CausalMutation
phenotype
CLINVAR
Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias.
20725928
2010
×
Entrez Id:
4513
Gene Symbol:
COX2
COX2
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
4567
Gene Symbol:
TRNL1
TRNL1
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
4952
Gene Symbol:
OCRL
OCRL
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
4572
Gene Symbol:
TRNQ
TRNQ
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
9247
Gene Symbol:
GCM2
GCM2
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
9949
Gene Symbol:
AMMECR1
AMMECR1
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
1080
Gene Symbol:
CFTR
CFTR
0.100
Biomarker
phenotype
HPO